Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
What's New at TheBody.com
  
  • Email Email
  • Glossary Glossary

 

Approval of Sofosbuvir/Ledipasvir Was Expected, but Still Is a Huge Advance

Paul E. Sax, M.D., Journal Watch; Posted Oct 15, 12:41 p.m. ET

"This is instantly a treatment of choice -- and for now, the treatment of choice -- for genotype 1 patients, and no doubt the HCV treatment guidelines will say as much when they're revised," writes Paul Sax, M.D.

Why Are We Still Having Silent Sex?

Mickyel "Micky" Bradford , HIV Prevention Justice Alliance; Posted Oct 14, 5:56 p.m. ET

How is silent sex the worst kind of sex? This new blog from the HIV Prevention Justice Alliance blog tour on black gay men in the U.S. South explains.

What's Hot in HIV Treatment

Warren Tong, TheBodyPRO.com; Posted Oct 14, 4:25 p.m. ET

Here's a recap of the biggest developments in HIV treatment over the past year, as well as a look at what's to come.

Fair Pricing Coalition Welcomes Approval of Gilead Sciences' Combination Tablet for Hepatitis C, Urges a Uniform Price for Curative Treatment

Fair Pricing Coalition; Posted Oct 14, 2:03 p.m. ET

Gilead has failed to comprehend that pricing its curative treatments beyond what the market can bear is a shortsighted business tactic and a failed public health opportunity.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?


Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?

 

Whether HIV Positive or Negative, Many Gay Men Could Benefit From HPV Vaccine

Mathew Rodriguez, TheBody.com; Posted Oct 12, 11:07 p.m. ET

Emerging patterns of HPV-related diseases strengthen the call for universal vaccination of both boys and girls, with consideration of catch-up and targeted vaccination of high-risk groups such as MSM and those with HIV infection.

FDA Approval Notice for Harvoni (Ledipasvir and Sofosbuvir)

U.S. Food and Drug Administration; Posted Oct 10, 5:19 p.m. ET

The U.S. Food and Drug Adminstration approved Harvoni, the first combination pill used to treat chronic hepatitis C infection, earlier today. It is the first approved regimen that does not require interferon or ribavirin.

Know Your Worth

Nolan Hill, TheBody.com; Posted Oct 10, 5:01 p.m. ET

"Never let anyone have power over your worth ... never let anyone control your voice."

Rebuilding Community as HIV Prevention

Justin C. Smith, HIV Prevention Justice Alliance; Posted Oct 10, 4:11 p.m. ET

How can HIV prevention help to restore community among young black gay men in the South?

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.

 

HIV Attachment Inhibitor BMS-663068 Compares Well to Boosted Atazanavir at 24 Weeks

Myles Helfand, TheBodyPRO.com; Posted Oct 10, 2:38 p.m. ET

In its bid to become the first approved member of a new class of HIV medications, the attachment inhibitor BMS-663068, also known as "068" or fostemsavir, showed similar efficacy to ritonavir (Norvir)-boosted atazanavir (Reyataz) in Phase 2b study results presented at IDWeek 2014.

BMS-986001 Bone, Metabolic Data Compare Well to Tenofovir Through 48 Weeks

Myles Helfand, TheBodyPRO.com; Posted Oct 10, 2:09 p.m. ET

Although most eyes have been focused on the development of tenofovir alafenamide fumarate (TAF), a less-toxic prodrug of tenofovir (Viread), another thymidine analog is moving through development as well. We spoke with Grace McComsey, M.D., about the latest data.

Why We Must Not Ignore the Lives of Older Black Gay Men

Craig Washington, HIV Prevention Justice Alliance; Posted Oct 9, 12:15 p.m. ET

How do we include black gay men over 50 when we talk about the way HIV affects black gay men?

Moving Forward the National Agenda for Women Living With HIV

Rusti Miller-Hill, TheBody.com; Posted Oct 8, 5:17 p.m. ET

Rusti Miller-Hill recently attended the PWN Summit in Florida. Here are her thoughts on the future of funding for programs and services for women living with HIV.


>> Browse Older Featured Stories

 


  
  • Email Email
  • Glossary Glossary
Advertisement